126 Early-phenotype Lewis Y CAR-T cells persist better in vivo and induce solid tumor regression in combination with anti-PD1
Main Authors: | Deborah Meyran, Joe Zhu, Jeanne Butler, Sean Macdonald, Daniela Tantalo, Niko Thio, Kevin Sek, Paul Ekert, Michael Kershaw, Joe Trapani, Phillip Darcy, Paul Neeson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Advances in CAR T cell immunotherapy for paediatric brain tumours
by: Padmashree Rao, et al.
Published: (2022-11-01) -
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
by: Rachael L. Terry, et al.
Published: (2021-09-01) -
Combining chemotherapy with CAR-T cell therapy in treating solid tumors
by: Arthur Xuan Wang, et al.
Published: (2023-03-01) -
Chimeric Antigen Receptor beyond CAR-T Cells
by: Vicky Mengfei Qin, et al.
Published: (2021-01-01) -
Generating CAR T cells from tumor-infiltrating lymphocytes
by: Jane K. Mills, et al.
Published: (2021-05-01)